AR034373A1 - Inhibidores de ptpasa para mejorar el perfil de riesgo cardiovascular - Google Patents
Inhibidores de ptpasa para mejorar el perfil de riesgo cardiovascularInfo
- Publication number
- AR034373A1 AR034373A1 ARP020102108A ARP020102108A AR034373A1 AR 034373 A1 AR034373 A1 AR 034373A1 AR P020102108 A ARP020102108 A AR P020102108A AR P020102108 A ARP020102108 A AR P020102108A AR 034373 A1 AR034373 A1 AR 034373A1
- Authority
- AR
- Argentina
- Prior art keywords
- risk profile
- cardiovascular risk
- improve cardiovascular
- ptpase inhibitors
- ptpase
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 abstract 2
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente provee métodos de uso de inhibidores de proteína-tirosina fosfatasa (PTPasa) para disminuir el perfil de riesgo cardiovascular en mamíferos que experimentan o que están sujetos a diabetes de tipo II o síndrome X que incluyen disminuir los niveles de lipoproteínas de la sangre, ácidos grasos libres y triglicéridos así como también tratar, prevenir o inhibir ateroesclerosis y otros desórdenes cardiovasculares y cerebrovasculares.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29646801P | 2001-06-07 | 2001-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034373A1 true AR034373A1 (es) | 2004-02-18 |
Family
ID=23142130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102108A AR034373A1 (es) | 2001-06-07 | 2002-06-06 | Inhibidores de ptpasa para mejorar el perfil de riesgo cardiovascular |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20030022896A1 (es) |
| AR (1) | AR034373A1 (es) |
| WO (1) | WO2002098408A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
| EP1732534B1 (en) * | 2004-02-27 | 2008-07-23 | Laboratoires Serono SA | Use of methylene amide derivatives in cardiovascular disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20000767A2 (en) * | 1998-05-12 | 2001-10-31 | American Home Prod | Benzothiophenes, benzofurans and indoles useful in the treatment of insulin resistance and hyperglycemia |
-
2002
- 2002-06-06 AR ARP020102108A patent/AR034373A1/es unknown
- 2002-06-06 WO PCT/US2002/018070 patent/WO2002098408A1/en not_active Ceased
- 2002-06-06 US US10/163,753 patent/US20030022896A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002098408A1 (en) | 2002-12-12 |
| US20030022896A1 (en) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0613358A8 (pt) | ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência | |
| CR6310A (es) | 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas | |
| ATE114970T1 (de) | Nicht absorbierbare cholesterin esterase hemmer zur verminderung der cholesterinabsorption. | |
| UY28243A1 (es) | Compuestos de quinolina y qunoxalina | |
| UY29222A1 (es) | Compuestos y derivados de dibencil amina | |
| PA8481201A1 (es) | 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-amino | |
| BR0207285A (pt) | Agonistas de ppar | |
| DK1766077T3 (da) | Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse | |
| BRPI0512864A (pt) | composições e métodos para o tratamento de condições e desordens oculares | |
| DK1729824T3 (da) | Phospholipidanaloger til behandling af cancere | |
| CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
| BR112015027377A2 (pt) | Compostos oligoméricos com grupos de conjugado, composições compreendendo os referidos compostos e usos dos mesmos | |
| BRPI0516515A (pt) | composições contendo lipase, protease e amilase para o tratamento da insuficiência pancreática | |
| TW200806215A (en) | Shoe stability layer apparatus and method | |
| AR047897A1 (es) | Composiciones y metodos que usan interferencia de arn para el control de nematodos | |
| CR8402A (es) | Indazol-o-glucosidos sustitutos | |
| ECSP088539A (es) | MÉTODO DE UTILIZACIÓN DE b-HIDROXI-b-METILBUTIRATO | |
| AR034023A1 (es) | Compuestos benzimidazoles para modular la ige e inhibir la proliferacion celular | |
| AR057274A1 (es) | Metodos para el tratamiento y la prevencion de fibrosis | |
| CR9012A (es) | Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina | |
| BRPI0515319A (pt) | análogos de quinolona | |
| DE60114996D1 (de) | Senkung des serum cholesterols | |
| AR034373A1 (es) | Inhibidores de ptpasa para mejorar el perfil de riesgo cardiovascular | |
| UY30042A1 (es) | Nuevos derivados de alquilfosfolípidos con citotoxicidad reducida y usos de los mismos. | |
| AR051932A1 (es) | Ciertas plantas con niveles de acidos grasos "no saturados", o saturados reducidos en semillas, y aceite derivado de las semillas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |